HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ash A Alizadeh Selected Research

Neutralizing Antibodies

3/2022CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ash A Alizadeh Research Topics

Disease

53Neoplasms (Cancer)
01/2022 - 04/2005
15Lymphoma (Lymphomas)
03/2022 - 10/2009
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 04/2003
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 04/2002
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2015
6B-Cell Lymphoma (Lymphoma, B Cell)
03/2022 - 02/2011
6Lung Neoplasms (Lung Cancer)
01/2022 - 01/2017
6Residual Neoplasm
01/2022 - 10/2015
4Neoplasm Metastasis (Metastasis)
01/2020 - 04/2012
3Disease Progression
10/2020 - 09/2004
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020 - 07/2012
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 09/2004
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2017 - 09/2010
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2010 - 05/2010
2Infections
01/2022 - 03/2012
2Sarcoma (Soft Tissue Sarcoma)
10/2021 - 12/2020
2Adenocarcinoma
01/2020 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 01/2017
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 12/2010
2Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
2T-Cell Lymphoma (Lymphoma, T Cell)
09/2012 - 03/2012
1COVID-19
03/2022
1Frailty
01/2022
1Glioma (Gliomas)
12/2020
1Esophageal Neoplasms (Esophageal Cancer)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Pain (Aches)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
11/2019
1Leiomyosarcoma
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
11/2017
1Extranodal Extension
01/2017
1B-Cell Leukemia (Leukemia, B Cell)
03/2015
1Genetic Translocation (Chromosomal Translocation)
12/2014
1Multiple Myeloma
07/2014
1Inflammation (Inflammations)
07/2013

Drug/Important Bio-Agent (IBA)

20Circulating Tumor DNAIBA
05/2022 - 05/2014
15DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2003
9Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2014
8Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2004
7Monoclonal AntibodiesIBA
01/2022 - 10/2009
7Immunoglobulins (Immunoglobulin)IBA
01/2019 - 02/2013
6Cell-Free Nucleic AcidsIBA
01/2022 - 11/2016
6AntigensIBA
01/2020 - 01/2002
4RNA (Ribonucleic Acid)IBA
12/2020 - 05/2015
3Biological ProductsIBA
01/2022 - 11/2016
3B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2017 - 07/2010
3Phosphotransferases (Kinase)IBA
01/2017 - 01/2013
3Rituximab (Mabthera)FDA Link
04/2013 - 09/2010
3Messenger RNA (mRNA)IBA
07/2012 - 07/2010
2ChromatinIBA
01/2022 - 03/2015
2Immune Checkpoint InhibitorsIBA
10/2020 - 01/2019
2VaccinesIBA
01/2020 - 11/2019
2Peptides (Polypeptides)IBA
11/2019 - 01/2017
2Immunoglobulin Variable RegionIBA
01/2017 - 11/2012
2Interleukin-6 (Interleukin 6)IBA
07/2013 - 01/2004
2Interleukin-4 (Interleukin 4)IBA
07/2013 - 04/2005
2AntibodiesIBA
04/2012 - 09/2010
2Complementary DNA (cDNA)IBA
08/2003 - 04/2002
1Immunoglobulin G (IgG)IBA
03/2022
1Neutralizing AntibodiesIBA
03/2022
1Blocking AntibodiesIBA
03/2022
1Ad26COVS1IBA
01/2022
1Sphingosine-1-Phosphate ReceptorsIBA
01/2022
1BNT162 VaccineIBA
01/2022
12019-nCoV Vaccine mRNA-1273IBA
01/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1Interferon-gamma (Interferon, gamma)IBA
01/2022
1SphingosineIBA
01/2022
1AnthracyclinesIBA
01/2022
1Flucytosine (Ancobon)FDA Link
12/2020
1GlutaminaseIBA
12/2020
1vocimagene amiretrorepvecIBA
12/2020
1Hormones (Hormone)IBA
01/2020
1AndrogensIBA
01/2020
1NucleotidesIBA
01/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2019
1EpitopesIBA
11/2019
1Immunoglobulin M (IgM)IBA
01/2019
1Phospholipases (Phospholipase)IBA
01/2017
1Syk KinaseIBA
01/2017
1src-Family KinasesIBA
01/2017
1Biological FactorsIBA
11/2016
1ErbB Receptors (EGF Receptor)IBA
10/2016
1rociletinibIBA
10/2016
1MHC class II transactivator proteinIBA
03/2015
1cytidylyl-(3'-5')-cytidine (CpC)IBA
07/2014
1Vincristine (Oncovin)FDA LinkGeneric
06/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014
1Prednisone (Sone)FDA LinkGeneric
06/2014
1Neoplasm Antigens (Tumor Antigens)IBA
05/2014

Therapy/Procedure

31Therapeutics
01/2022 - 10/2009
9Immunotherapy
12/2020 - 09/2012
5Drug Therapy (Chemotherapy)
05/2022 - 07/2010
4Radiotherapy
12/2020 - 10/2015
3Aftercare (After-Treatment)
01/2020 - 10/2015
1Stem Cell Transplantation
01/2020
1Chemoradiotherapy
01/2020
1Salvage Therapy
01/2020
1Surgical Instruments (Clip)
01/2020
1Precision Medicine
07/2014